SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-117964
Filing Date
2021-04-15
Accepted
2021-04-15 17:28:03
Documents
2
Group Members
ACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCCLAL BIOTECHNOLOGY INDUSTRIES LTD.LEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d135446dsc13da.htm SC 13D/A 98466
2 EX-99.9 d135446dex999.htm EX-99.9 7475
  Complete submission text file 0001193125-21-117964.txt   107883
Mailing Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019 212 247 6400
Access Industries Holdings LLC (Filed by) CIK: 0001391297 (see all company filings)

IRS No.: 721620814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86953 | Film No.: 21829454
SIC: 2834 Pharmaceutical Preparations